Libya vs Singapore: Cause of death, by non-communicable diseases, ages 60+, female
Libya
73.9%
in 2021
Singapore
73.7%
in 2021
Libya rank
96th
Singapore rank
98th
Cause of death, by non-communicable diseases, ages 60+, female over time
- Libya
- Singapore
How they compare
Libya currently reports 73.9% against 73.7% in Singapore, a difference of 0.2%.
Across all 6 years both countries report, Libya has been ahead every year.
Libya ranks 96th and Singapore ranks 98th of 185 countries.
Libya has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Libya | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 91.9% | 82.0% | 9.9% | Libya |
| 2010s | 91.8% | 73.6% | 18.2% | Libya |
| 2020s | 78.3% | 74.5% | 3.8% | Libya |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, female, Libya or Singapore?
- Libya, at 73.9% against 73.7% in Singapore as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+, female between Libya and Singapore?
- 0.2%, with Libya ahead.
- How many years of comparable data are there for Libya and Singapore?
- 6 years are reported by both, from 2000 to 2021.
- How do Libya and Singapore rank globally for cause of death, by non-communicable diseases, ages 60+, female?
- Libya ranks 96th and Singapore ranks 98th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+, female (% of total female deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 60+ due to non-communicable diseases divided by number of all female deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.